|
US5451575A
(en)
|
1988-02-19 |
1995-09-19 |
J. W. Broadbent Nominees Pty., Ltd. |
Method of treating liver dysfunction with 24-R scymnol
|
|
US5786457A
(en)
|
1989-02-23 |
1998-07-28 |
Colorado State University Research Foundation |
Hormone-nuclease compounds and method for regulating hormone related diseases
|
|
AU5186090A
(en)
|
1989-02-23 |
1990-09-26 |
Colorado State University Research Foundation |
Gnrh analogs for destroying gonadotrophs
|
|
US5273738A
(en)
|
1990-03-03 |
1993-12-28 |
Fred Hutchinson Cancer Research Center |
Radiation delivery to lymphoid and marrow tissues
|
|
US5367057A
(en)
|
1991-04-02 |
1994-11-22 |
The Trustees Of Princeton University |
Tyrosine kinase receptor flk-2 and fragments thereof
|
|
DK0578774T3
(da)
|
1991-04-05 |
1999-04-26 |
Univ Washington |
Monoklonale antistoffer mod stamcellefaktor-receptorer
|
|
WO1993015751A1
(en)
|
1992-02-14 |
1993-08-19 |
Merck & Co., Inc. |
CHIMERIC TOXINS BINDING TO THE GnRH RECEPTOR
|
|
CA2161771C
(en)
|
1993-04-30 |
2009-01-13 |
L. David Tomei |
Methods of identifying potentially therapeutically effective agents and cell strains for use therein
|
|
US6024957A
(en)
|
1993-06-02 |
2000-02-15 |
Research Corporation Technologies, Inc. |
Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
|
|
US6106834A
(en)
|
1993-06-02 |
2000-08-22 |
Research Corporation Technologies, Inc. |
Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
|
|
AU7832394A
(en)
|
1993-09-08 |
1995-03-27 |
Imclone Systems Incorporated |
Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
|
|
GB2282812A
(en)
|
1993-10-15 |
1995-04-19 |
Merck & Co Inc |
Cytotoxic/receptor ligand conjugates linked via lysine radicals
|
|
GB9323199D0
(en)
|
1993-11-10 |
1994-01-05 |
Falkenberg J H F |
Leukaemia treatment
|
|
DE4343261C2
(de)
|
1993-12-17 |
1995-11-02 |
Susanne Holzer |
Verfahren zur präparativen Herstellung von Ausgangsstoffen für Immunoassays und Bioassays
|
|
US5635388A
(en)
|
1994-04-04 |
1997-06-03 |
Genentech, Inc. |
Agonist antibodies against the flk2/flt3 receptor and uses thereof
|
|
DE19600589C1
(de)
|
1996-01-10 |
1997-01-16 |
Univ Eberhard Karls |
Antikörper A3C6E2
|
|
DE19608769C1
(de)
|
1996-03-07 |
1997-04-10 |
Univ Eberhard Karls |
Antikörper BV10A4H2
|
|
RU2192281C2
(ru)
|
1996-10-11 |
2002-11-10 |
Бристол-Маерс Сквибб Компани |
Способы и композиции для иммуномодуляции
|
|
CA2284726A1
(en)
|
1997-04-11 |
1998-10-22 |
G.D. Searle & Co. |
Antagonistic anti-avb3 integrin antibodies
|
|
DE19727814C1
(de)
|
1997-06-30 |
1998-10-01 |
Univ Eberhard Karls |
Anitkörper 4G8B4B12
|
|
DE19808453C2
(de)
|
1998-02-27 |
2000-12-14 |
Gsf Forschungszentrum Umwelt |
Expressionsvektor zur konditionalen Regulation der Expression der großen Untereinheit der RNA-Polymerase II
|
|
US6339062B1
(en)
|
1998-11-23 |
2002-01-15 |
Inkine Pharmaceutical Company, Inc. |
Retroinverso polypeptides that mimic or inhibit thrombospondin activity
|
|
US6831071B2
(en)
|
1999-04-08 |
2004-12-14 |
Pavel Sergeev |
Synthesis of biologically active compounds in cells
|
|
US6159443A
(en)
|
1999-04-29 |
2000-12-12 |
Vanderbilt University |
X-ray guided drug delivery
|
|
AUPQ014799A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using polymers
|
|
AUPQ014699A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
WO2002032955A1
(en)
|
2000-10-18 |
2002-04-25 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services. |
Human gene critical to fertility
|
|
AU2002218006A1
(en)
|
2000-11-03 |
2002-05-15 |
Dana Farber Cancer Institute |
Compositions and methods for the diagnosis of cancer
|
|
US20050069538A1
(en)
|
2003-09-18 |
2005-03-31 |
Gregorio Aversa |
Therapeutic binding molecules
|
|
GB0110430D0
(en)
|
2001-04-27 |
2001-06-20 |
Medical Res Council |
Protein variants and uses thereof
|
|
GB0122914D0
(en)
|
2001-09-22 |
2001-11-14 |
Univ Nottingham |
Modulation of stat activity
|
|
CN1184890C
(zh)
|
2001-10-09 |
2005-01-19 |
湖南师范大学 |
含鹅膏肽毒素基因的苏云金杆菌工程菌双效杀虫剂
|
|
AU2002351204B2
(en)
|
2001-12-03 |
2008-07-10 |
Abgenix, Inc. |
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
|
|
AR037756A1
(es)
|
2001-12-17 |
2004-12-01 |
Bayer Corp |
Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma.
|
|
US7183385B2
(en)
|
2002-02-20 |
2007-02-27 |
Cell Signaling Technology, Inc. |
Phospho-specific antibodies to Flt3 and uses thereof
|
|
US20030232369A1
(en)
|
2002-04-17 |
2003-12-18 |
Bushnell David A. |
Molecular structure of RNA polymerase II
|
|
DE10219866A1
(de)
|
2002-05-03 |
2003-11-20 |
Isolde Riede-Kainrath |
Tumorprävention und Therapie durch Modifikation von "switch"-Genen oder RNA-Polymerase II-Aktivität
|
|
WO2004002425A2
(en)
|
2002-06-28 |
2004-01-08 |
Bio Transplant, Inc. |
Process for promoting graft acceptance by depletion of hematopoietic stem cells
|
|
AU2002953073A0
(en)
|
2002-11-21 |
2003-01-16 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of biotin-mediated targeting
|
|
US7166691B2
(en)
|
2002-12-20 |
2007-01-23 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Saposin C and receptors as targets for treatment of benign and malignant disorders
|
|
WO2006002064A2
(en)
|
2004-06-14 |
2006-01-05 |
Aerovance, Inc. |
Antibody inhibiting stem cell factor activity and use for treatment of asthma
|
|
US20060014197A1
(en)
|
2004-07-15 |
2006-01-19 |
Wisconsin Alumni Research Foundation |
In vivo screening methods for identifying inhibitors of RNA polymerases
|
|
CN103251953A
(zh)
|
2004-07-19 |
2013-08-21 |
约翰·霍普金斯大学 |
供免疫抑制的flt3抑制剂
|
|
EP1661584A1
(en)
|
2004-11-26 |
2006-05-31 |
Heinz Dr. Faulstich |
Use of conjugates of amatoxins and phallotoxins with macromolecules for cancer and inflammation therapy
|
|
CA2609751A1
(en)
|
2005-05-24 |
2006-11-30 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
|
US20110014151A1
(en)
|
2006-01-11 |
2011-01-20 |
Biotech Igg Ab |
Macromolecule conjugate
|
|
WO2007087453A2
(en)
|
2006-01-27 |
2007-08-02 |
Cellerant Therapeutics, Inc. |
Compositions and methods for treating haematological proliferative disorders
|
|
EP2015782A4
(en)
|
2006-04-12 |
2010-04-07 |
Crosslink Genetics Corp |
COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之ｃ-ｋｉｔ抗體
|
|
ES2371085T3
(es)
|
2006-05-27 |
2011-12-27 |
Faulstich, Heinz, Dr. |
Utilización de conjugados de amatoxinas o falotoxinas con macromoléculas para la terapia tumoral y de la inflamación.
|
|
ES2882360T3
(es)
*
|
2006-11-03 |
2021-12-01 |
Univ Leland Stanford Junior |
Inmunoempobrecimiento selectivo de un nicho de células madre endógenas para injerto
|
|
US20100093008A1
(en)
|
2007-03-02 |
2010-04-15 |
Cell Signaling Technology, Inc. |
Phospho-specific antibodies to flt3 (tyr969) and uses thereof
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
CA2694983A1
(en)
|
2007-07-17 |
2009-01-22 |
Combinatorx, Incorporated |
Treatments of b-cell proliferative disorders
|
|
US9518097B2
(en)
|
2007-11-09 |
2016-12-13 |
Board Of Trustees Of Michigan State University |
Identification and use of genes encoding amatoxin and phallotoxin
|
|
AR071891A1
(es)
|
2008-05-30 |
2010-07-21 |
Imclone Llc |
Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano)
|
|
WO2010045218A1
(en)
|
2008-10-13 |
2010-04-22 |
Board Of Regents, The University Of Texas System |
Molecular clock mechanism of hybrid vigor
|
|
WO2010081015A1
(en)
|
2009-01-09 |
2010-07-15 |
The Regents Of The University Of California |
Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening
|
|
JP2012523383A
(ja)
|
2009-04-08 |
2012-10-04 |
ファウルシュティヒ，ハインツ |
がんの治療のためのアマトキシンと複合体形成した標的結合部分
|
|
US9233173B2
(en)
*
|
2009-04-08 |
2016-01-12 |
Deutsches Krebsforschungszentrum |
Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
|
|
WO2010136508A2
(en)
*
|
2009-05-28 |
2010-12-02 |
Glaxo Group Limited |
Stem cell targeting
|
|
JP6114936B2
(ja)
*
|
2009-08-31 |
2017-04-19 |
イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． |
強力な細胞毒性活性を示すランピルナーゼ（ｒａｐ）を含む免疫毒素の組成物及び使用方法
|
|
US8518405B2
(en)
|
2009-10-08 |
2013-08-27 |
The University Of North Carolina At Charlotte |
Tumor specific antibodies and uses therefor
|
|
CA2951341A1
(en)
|
2009-12-21 |
2011-06-30 |
Keygene N.V. |
Improved techniques for transfecting protoplasts
|
|
HRP20160422T1
(hr)
|
2009-12-23 |
2016-05-20 |
Synimmune Gmbh |
Protutijela protiv flt3 postupci njihove upotrebe
|
|
US9109227B2
(en)
|
2010-01-05 |
2015-08-18 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
FLT3 receptor antagonists for the treatment or the prevention of pain disorders
|
|
KR20110085038A
(ko)
|
2010-01-19 |
2011-07-27 |
울산대학교 산학협력단 |
항 ｃｄ137-항체 및 독소 결합물을 이용한 ｃｄ137 양성세포의 제거방법
|
|
CN101861796B
(zh)
|
2010-05-18 |
2012-02-15 |
四川大学 |
一种利用有色稻米发酵废糟培养豹斑毒鹅膏的方法
|
|
EP2603231B1
(en)
|
2010-07-13 |
2021-12-29 |
Rhode Island Board Of Governors For Higher Education |
Compositions comprising a pH-sensitive membrane insertion polipeptide.
|
|
PT2614082T
(pt)
|
2010-09-09 |
2018-12-03 |
Pfizer |
Moléculas de ligação a 4-1bb
|
|
ES2402254T3
(es)
|
2010-09-30 |
2013-04-30 |
Heidelberg Pharma Ag |
Conjugados de amatoxinas con ligadores mejorados
|
|
EP2656079A2
(en)
|
2010-12-20 |
2013-10-30 |
Universiteit Gent |
Crystal structure of flt3 ligand-receptor complex
|
|
CN102526034B
(zh)
|
2010-12-24 |
2015-02-25 |
四川大学华西医院 |
恒河猴爆发性肝功能衰竭模型的建立
|
|
US9540443B2
(en)
|
2011-01-26 |
2017-01-10 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies
|
|
EP2497499A1
(en)
|
2011-03-10 |
2012-09-12 |
Heidelberg Pharma GmbH |
Amatoxin-conjugates with improved linkages
|
|
AR086044A1
(es)
*
|
2011-05-12 |
2013-11-13 |
Imclone Llc |
Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos
|
|
WO2013131927A1
(en)
|
2012-03-06 |
2013-09-12 |
Novartis Ag |
Combining dna-damaging agents and modulators of actin polymerization for the treatment of cancer
|
|
US9981046B2
(en)
|
2012-05-15 |
2018-05-29 |
Concortis Biosystems, Corp., a wholly owned Subsidiary of Sorrento Therapeutics, Inc. |
Drug-conjugates, conjugation methods, and uses thereof
|
|
WO2013192546A1
(en)
|
2012-06-22 |
2013-12-27 |
Cytomx Therapeutics, Inc. |
Activatable antibodies having non-binding steric moieties and mehtods of using the same
|
|
EP2684865A1
(en)
|
2012-07-13 |
2014-01-15 |
Heidelberg Pharma GmbH |
Methods for synthesizing amatoxin building block and amatoxins
|
|
CN102786586A
(zh)
|
2012-07-20 |
2012-11-21 |
包海鹰 |
玫瑰红鹅膏发酵菌丝体中肽类毒素的发现
|
|
CN116574185A
(zh)
|
2012-07-25 |
2023-08-11 |
塞尔德克斯医疗公司 |
抗kit抗体及其用途
|
|
US20150218220A1
(en)
|
2012-09-12 |
2015-08-06 |
Brian Alan MENDELSOHN |
Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase
|
|
SG10201702387YA
(en)
|
2012-09-24 |
2017-04-27 |
Medimmune Ltd |
Cell lines
|
|
GB201217296D0
(en)
|
2012-09-27 |
2012-11-14 |
Alta Innovations Ltd |
Method of treatment and/or prevention
|
|
EP2908818A4
(en)
|
2012-10-16 |
2016-07-13 |
Endocyte Inc |
CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE
|
|
ES2871816T3
(es)
|
2012-12-27 |
2021-11-02 |
Sanofi Sa |
Anticuerpos anti-LAMP1 y conjugados anticuerpo-fármaco, y usos de los mismos
|
|
EP2774624A1
(en)
|
2013-03-04 |
2014-09-10 |
Heidelberg Pharma GmbH |
Amatoxin derivatives
|
|
EP2968591A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Novartis AG |
Cell proliferation inhibitors and conjugates thereof
|
|
NZ710929A
(en)
|
2013-03-15 |
2018-02-23 |
Novartis Ag |
Antibody drug conjugates
|
|
AU2014299561B2
(en)
|
2013-06-24 |
2017-06-08 |
Ablbio |
Antibody-drug conjugate having improved stability and use thereof
|
|
WO2015006554A1
(en)
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
FR3008408B1
(fr)
*
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
JP6439690B2
(ja)
|
2013-07-12 |
2018-12-19 |
石原産業株式会社 |
細胞への遺伝子導入用組成物
|
|
AU2014293116A1
(en)
|
2013-07-23 |
2016-02-18 |
Ohio State Innovation Foundation |
Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
|
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
|
WO2015067667A1
(en)
*
|
2013-11-05 |
2015-05-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human neutralizing anti-kit antibodies and uses thereof
|
|
CN103627757B
(zh)
|
2013-12-02 |
2016-04-13 |
云南大学 |
提高小豹斑鹅膏菌丝体产毒能力的方法
|
|
CN105377304B
(zh)
*
|
2014-03-10 |
2018-05-15 |
海德堡医药有限责任公司 |
鹅膏毒肽衍生物
|
|
CA2940451A1
(en)
|
2014-03-12 |
2015-09-17 |
Novartis Ag |
Specific sites for modifying antibodies to make immunoconjugates
|
|
EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
AU2015292498B2
(en)
|
2014-07-23 |
2020-11-05 |
Ohio State Innovation Foundation |
Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
|
|
FI3656869T4
(fi)
|
2014-08-26 |
2025-06-04 |
Univ Leland Stanford Junior |
Kantasolujen siirrostaminen kantasoluihin kohdentuvan aineen ja immunoregulatorista signaalia moduloivan aineen yhdistelmän kanssa
|
|
WO2016036334A1
(en)
|
2014-09-03 |
2016-03-10 |
Şahi̇n Yücel |
Voltametric methods to determine alpha-amanitin and phalloidin
|
|
US20170224758A1
(en)
|
2014-10-17 |
2017-08-10 |
The Broad Institute, Inc. |
Compositions and methods of treating muscular dystrophy
|
|
EP3215519A1
(en)
|
2014-11-06 |
2017-09-13 |
Novartis AG |
Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
|
|
MX2017006016A
(es)
|
2014-11-11 |
2017-06-19 |
Amunix Operating Inc |
Composiciones conjugadas de xten direccionadas y metodos para producir las mismas.
|
|
US20160220687A1
(en)
|
2015-02-02 |
2016-08-04 |
National Guard Health Affairs |
Metalloproteinase-cleavable alpha-amanitin-dendrimer conjugates and method of treating cancer
|
|
SG10202006863YA
(en)
|
2015-02-16 |
2020-08-28 |
Lonza Ag |
Cl and/or ch1 mutated antibodies for drug conjugation
|
|
HRP20201791T1
(hr)
|
2015-03-04 |
2021-04-16 |
Board Of Regents, The University Of Texas System |
Postupci za liječenje raka sa hemizigotnim gubitkom gena tp53
|
|
ES2884844T3
(es)
|
2015-03-09 |
2021-12-13 |
Agensys Inc |
Conjugados de anticuerpo fármaco (ADC) que se unen a proteínas FLT3
|
|
JP6863900B2
(ja)
|
2015-03-09 |
2021-04-21 |
ハイデルベルク ファルマ リサーチ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規アマトキシン−抗体コンジュゲート
|
|
WO2016145014A1
(en)
|
2015-03-10 |
2016-09-15 |
President And Fellows Of Harvard College |
Methods for treatment of autism spectrum disorders
|
|
US10889646B2
(en)
|
2015-03-25 |
2021-01-12 |
Children's Hospital Medical Center |
Use of KIT inhibitors to condition subjects for a hematopoietic stem cell (HSC) transplantation
|
|
HK1249534A1
(zh)
*
|
2015-04-06 |
2018-11-02 |
哈佛大学校长及研究员协会 |
用於非清髓性预处理的组合物和方法
|
|
US10683506B2
(en)
|
2015-04-10 |
2020-06-16 |
The Methodist Hospital System |
CD117 ligand-drug conjugates for targeted cancer therapy
|
|
WO2016168471A1
(en)
|
2015-04-17 |
2016-10-20 |
Endocyte, Inc. |
Dual disulfide drug conjugates
|
|
CN104862314B
(zh)
|
2015-05-11 |
2017-12-01 |
昆明理工大学 |
一种与α‑鹅膏毒肽特异结合的核酸适配体及应用
|
|
RU2017138083A
(ru)
|
2015-05-18 |
2019-06-18 |
Универсидади Ду Порту |
Применение полимиксина в качестве антидота при отравлениях аматоксинами
|
|
WO2016191186A1
(en)
|
2015-05-22 |
2016-12-01 |
Memorial Sloan Kettering Cancer Center |
Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
|
|
US11384104B2
(en)
|
2015-06-19 |
2022-07-12 |
Centurion Biopharma Corporation |
Delivery systems for controlled drug release
|
|
US10961308B2
(en)
|
2015-06-29 |
2021-03-30 |
The General Hospital Corporation |
Embigin inhibition for promotion of hematopoietic stem and progenitor cell expansion
|
|
HK1255234A1
(zh)
|
2015-07-16 |
2019-08-09 |
塞勒兰特治疗公司 |
经半胱氨酸取代的免疫球蛋白
|
|
GB201601073D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies
|
|
JP7062290B2
(ja)
|
2015-07-31 |
2022-05-06 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． |
がんに対する免疫チェックポイント阻害剤との併用療法における造血幹細胞
|
|
CN105177009B
(zh)
|
2015-08-10 |
2018-05-25 |
昆明理工大学 |
一种与α-鹅膏毒肽特异结合的核酸适配体及应用
|
|
MY195114A
(en)
|
2016-02-04 |
2023-01-10 |
Robert Yongxin Zhao |
Specific Conjugation Linkers, Specific Immunoconjugates Thereof, Methods of Making and uses Such Conjugates Thereof
|
|
CN106153768B
(zh)
|
2016-06-30 |
2019-01-01 |
佛山科学技术学院 |
鹅膏毒肽分子印迹材料用于α-amanitin和β-amanitin的固相萃取方法
|
|
CA3045592A1
(en)
*
|
2016-12-21 |
2018-06-28 |
Novartis Ag |
Antibody drug conjugates for ablating hematopoietic stem cells
|